Biontech Se (BNTX) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket
 


Biontech Se  (NASDAQ: BNTX)


Biontech Se's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biontech Se's ROI in the fourth quarter of 2025?
Biontech Se had a negative return on investment (ROI) of -5.66%, due to the net loss of $-1 billion, during the twelve months ending in the fourth quarter of 2025.

Within the Healthcare sector 291 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 3258.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 2.24 % -3.26 % -4.17 % -5.05 % -5.92 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 23,263 22,228 22,228 22,228 20,756
Return On Investment (TTM) -5.66 % -3.41 % -3.4 % -3.39 % -3.39 %
BNTX's Overall Ranking # 3258 # 0 # # #
Seq. Investment Change TTM 2.87 % -0.2 % -0.2 % -0.2 % -2.67 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1,272 -745 -745 -745 -745




Return On Investment BNTX's Ranking
Within: No.
Industry # 33
Sector # 292
Overall # 3258

Return On Investment Statistics
High Average Low
83.35 %
14.12 %
-27.17 %
(Dec 31 2021)   (Dec 31 2019)



  News about Biontech Se Return on Investment ROI

BioNTechs AI Day Marks a New Era in Drug Discovery Innovation on October 1, 2024,

September 17, 2024

On October 1, 2024, BioNTech SE (NASDAQ: BNTX) is set to showcase its commitment to cutting-edge science by hosting an AI Day as part of its ongoing Innovation Series. This event promises to be a vital platform for discussing the intersection of artificial intelligence and biotechnology, reflecting the company s dedication to staying at the forefront of drug discovery and development.BioNTech, renowned for its pioneering mRNA technology used in COVID-19 vaccines, has continuously sought to innovate within the pharmaceutical industry. The upcoming AI Day aligns with the company’s aim to leverage advanced technologies for improving therapeutic strategies and patient outcomes. By focusing on artificial intelligence, BioNTech is poised to explore its applications in drug discovery, biomarker identification, clinical trial optimization, and personalized medicine.






Financial Statements
Biontech Se's IV. Quarter Investments $ 23,263 Millions BNTX's Balance sheet
Biontech Se's IV. Quarter Income $ -1,272 Millions Quarterly BNTX's Income Statement
BNTX's Income by Division See BNTX's Income by Division


BNTX Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 23,263 20,756 23,168 21,761 13,972
Y / Y Investment Growth 12.08 % -10.41 % 6.47 % 55.74 % 578.48 %
Net Income in Millions -1,284 -720 1,006 9,938 12,176
Y / Y Net Income Growth - - -89.88 % -18.38 % 70115.83 %
Annual Return On Investment -5.52 % -3.47 % 4.34 % 45.67 % 87.15 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BNTX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BNTX's Competitors
Subscribers only: Roi for Biontech Se's Suppliers
Subscribers only: Return On Investment for BNTX's Customers

Other Ratios
BNTX's Roa BNTX's Inventory Turnover Ratio BNTX's Growth Rates BNTX's Dividend Statistics
BNTX's Profitability Ratios BNTX's Asset Turnover Ratio BNTX's Dividend Growth
BNTX's Roe BNTX's Valuation Ratios BNTX's Financial Strength Ratios BNTX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI


Date modified: 2026-07-07T09:38:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.